1. Home
  2. NTRS vs RMD Comparison

NTRS vs RMD Comparison

Compare NTRS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Trust Corporation

NTRS

Northern Trust Corporation

HOLD

Current Price

$164.85

Market Cap

31.1B

Sector

Finance

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$192.03

Market Cap

29.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRS
RMD
Founded
1889
1989
Country
United States
United States
Employees
23800
10600
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.1B
29.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NTRS
RMD
Price
$164.85
$192.03
Analyst Decision
Hold
Buy
Analyst Count
12
10
Target Price
$163.55
$292.56
AVG Volume (30 Days)
815.6K
1.4M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
1.94%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.40
$10.60
Revenue Next Year
$4.13
$7.41
P/E Ratio
$16.88
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$104.99
$198.61
52 Week High
$173.19
$293.81

Technical Indicators

Market Signals
Indicator
NTRS
RMD
Relative Strength Index (RSI) 54.36 27.83
Support Level $158.98 N/A
Resistance Level $173.19 $260.21
Average True Range (ATR) 2.99 5.34
MACD -0.27 0.01
Stochastic Oscillator 54.26 4.76

Price Performance

Historical Comparison
NTRS
RMD

About NTRS Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2025, Northern Trust had assets under custody or administration of $18.7 trillion and assets under management of $1.8 trillion.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: